Actively Recruiting
Local Anesthesia for Facial Fractures
Led by Washington University School of Medicine · Updated on 2026-02-25
70
Participants Needed
1
Research Sites
169 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is a double-blind randomized, placebo controlled trial examining the impact of perioperative bupivacaine nerve block on PACU recovery metrics. Patients with operative facial fractures are randomized to receive either bupivacaine or saline injections prior to the anesthesia emergence.
CONDITIONS
Official Title
Local Anesthesia for Facial Fractures
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults age 18 and over
- Isolated facial fracture to the mandible and/or midface undergoing surgical repair
- No allergy to local anesthetic
- Ability to read, write, and understand English
You will not qualify if you...
- Patients under the age of 18
- Isolated nasal bone fracture
- Polytrauma (I.e. injury pattern resulting in hospital admission for multiple bony fractures outside of the face)
- Allergy to local anesthetic
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Washington University
St Louis, Missouri, United States, 63110
Actively Recruiting
Research Team
A
Amrita Hari-Raj, MD
CONTACT
S
Sara Kukuljan
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here